5-Bromo-2-Cyanopyridine CAS 97483-77-7 Purity ≥99.0% (HPLC) Tedizolid Phosphate Intermediate

Short Description:

Chemical Name: 5-Bromo-2-Cyanopyridine 

CAS: 97483-77-7

Purity: ≥99.0% (HPLC)

Appearance: Off-White to Pale Yellow Powder 

Intermediate of Tedizolid Phosphate (CAS: 856867-55-5) for the treatment of ABSSSI 

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Manufacturer Supply, High Purity, Commercial Production 
Chemical Name: 5-Bromo-2-Cyanopyridine 
CAS: 97483-77-7

Chemical Properties:

Chemical Name 5-Bromo-2-Cyanopyridine
Synonyms 5-Bromo-2-Pyridinecarbonitrile; 5-Bromopicolinonitrile
CAS Number 97483-77-7
CAT Number RF-PI610
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C6H3BrN2
Molecular Weight 183.01
Melting Point 128.0~132.0℃ (lit.)
Boiling Point 100.0-110.0℃/3 mmHg (lit.)
Solubility Soluble in Methanol
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance Off-White to Pale Yellow Powder
Purity / Analysis Method ≥99.0% (HPLC)
Moisture (K.F) ≤0.50%
Total Impurities ≤1.0%
Test Standard Enterprise Standard
Usage Intermediate of Tedizolid Phosphate (CAS: 856867-55-5)

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

Advantages:

1

FAQ:

Application:

5-Bromo-2-Cyanopyridine (CAS: 97483-77-7) is an organic synthesis and pharmaceutical intermediate, which can be mainly used in laboratory research and chemical production process. 5-Bromo-2-Cyanopyridine is the intermediate of Tedizolid Phosphate (CAS: 856867-55-5). Tedizolid Phosphate is a new anti-bacterial drug developed by CUBIST PHARMS company. Tedizolid phosphate is a prodrug of Tedizolid. After oral or intravenous administration, Tedizolid phosphate is converted to Tedizolid by phosphatase. Tedizolid is the second generation of oxazolidinone antibiotics, a protein synthesis inhibitors. binding the 50S subunit of bacterial ribosomes, it can inhibit protein synthesis and play a role of antibacterial. On June 20, 2014, the US Food and Drug Administration (FDA) approved Tedizolid phosphate for use in certain sensitive bacterial-induced adult acute bacterial skin and skin structure infections (ABSSSI), with trade name SIVEXTRO.

  • Write your message here and send it to us